Metraipolis › archive › dc_4a339bb751fa

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? — Europe PMC PMID:40940908

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40940908
DOI: 10.3390/cancers17172811
License (as archived): solo-consultazione
Archived: 2026-11-10T07:38:20.644Z
SHA-256 of the archived text: 5cdb0a08ff48719e11331734b777b17d4c1b35c3ac4116ecd385af85c59af9d8
Stable URL of this page: https://metraipolis.com/documento/dc_4a339bb751fa

How to cite

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? — Europe PMC PMID:40940908 — Europe PMC (en), https://europepmc.org/article/MED/40940908 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a339bb751fa (Metraipolis archive dc_4a339bb751fa, sha256 5cdb0a08ff48719e11331734b777b17d4c1b35c3ac4116ecd385af85c59af9d8)

BibTeX

@misc{dc4a339bb751fa,
  title = {Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? — Europe PMC PMID:40940908},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940908},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a339bb751fa; sha256 5cdb0a08ff48719e11331734b777b17d4c1b35c3ac4116ecd385af85c59af9d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940908. Agents can read the archived copy with the MCP tool read_document.